1. Home
  2. KMPR vs AMLX Comparison

KMPR vs AMLX Comparison

Compare KMPR & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

KMPR

Kemper Corporation

HOLD

Current Price

$28.51

Market Cap

1.7B

Sector

Finance

ML Signal

HOLD

Logo Amylyx Pharmaceuticals Inc.

AMLX

Amylyx Pharmaceuticals Inc.

HOLD

Current Price

$22.82

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KMPR
AMLX
Founded
1990
2014
Country
United States
United States
Employees
7400
N/A
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
2.0B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
KMPR
AMLX
Price
$28.51
$22.82
Analyst Decision
Hold
Strong Buy
Analyst Count
5
9
Target Price
$47.67
$21.56
AVG Volume (30 Days)
813.2K
1.9M
Earning Date
05-06-2026
05-07-2026
Dividend Yield
3.85%
N/A
EPS Growth
N/A
65.46
EPS
N/A
N/A
Revenue
N/A
$380,786,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$4.35
N/A
P/E Ratio
$14.38
N/A
Revenue Growth
N/A
1612.94
52 Week Low
$22.69
$7.61
52 Week High
$54.90
$24.36

Technical Indicators

Market Signals
Indicator
KMPR
AMLX
Relative Strength Index (RSI) 56.87 76.43
Support Level $29.76 $12.46
Resistance Level $30.97 N/A
Average True Range (ATR) 1.16 1.43
MACD 0.01 0.39
Stochastic Oscillator 67.92 97.69

Price Performance

Historical Comparison
KMPR
AMLX

About KMPR Kemper Corporation

Kemper Corp is an insurance holding company that offers complementary insurance products through its subsidiaries, including personal and commercial automobile insurance to consumers in targeted markets and industries. Kemper also offers life and other insurance solutions based on the needs of its clients. The company offers its insurance products through a vast network of agents and brokers, mainly under the Kemper Auto and Kemper Life brands. It has two operating segments: Specialty Property & Casualty Insurance and Life Insurance. The majority of the company's revenue is generated from the Specialty Property & Casualty Insurance segment, whose principal products are specialty personal automobile and commercial automobile insurance. Geographically, it operates only in the United States.

About AMLX Amylyx Pharmaceuticals Inc.

Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on developing novel therapies for communities with high unmet medical needs. The company has preclinical and clinical development programs in endocrine conditions and neurodegenerative diseases. Its pipeline includes investigational therapies matched with diseases based on mechanistic rationale, clinical outcomes, biomarkers, and preclinical data. The company is currently developing avexitide for Post-Bariatric Hypoglycemia, AMX0035 for Wolfram Syndrome, AMX0114 for Amyotrophic Lateral Sclerosis, and AMX0318 for Post-Bariatric Hypoglycemia and other rare diseases.

Share on Social Networks: